DrugPatentWatch Database Preview
Cimetidine - Generic Drug Details
» See Plans and Pricing
What are the generic sources for cimetidine and what is the scope of freedom to operate?
Cimetidine
is the generic ingredient in seven branded drugs marketed by Glaxosmithkline, Apotex, Chartwell Molecules, Contract Pharmacal, Cycle Pharms Ltd, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Perrigo, Pliva, Sandoz Inc, Teva, Upsher Smith Labs, Watson Labs Inc, Watson Labs Teva, Yaopharma Co Ltd, Medtech Products, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Akorn, Ani Pharms Inc, G And W Labs Inc, Lannett Co Inc, Pharm Assoc, and Wockhardt Bio Ag, and is included in fifty-five NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-five drug master file entries for cimetidine. Eighteen suppliers are listed for this compound.
Summary for cimetidine
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 29 |
NDAs: | 55 |
Drug Master File Entries: | 25 |
Suppliers / Packagers: | 18 |
Bulk Api Vendors: | 136 |
Clinical Trials: | 56 |
Patent Applications: | 6,379 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for cimetidine |
What excipients (inactive ingredients) are in cimetidine? | cimetidine excipients list |
DailyMed Link: | cimetidine at DailyMed |
Recent Clinical Trials for cimetidine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | N/A |
Esam Hamed | N/A |
Wafaa Hamza | N/A |
Pharmacology for cimetidine
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for cimetidine
US Patents and Regulatory Information for cimetidine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett Co Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 074251-001 | Dec 22, 1994 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Teva Parenteral | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074252-001 | Nov 26, 1997 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Watson Labs Inc | CIMETIDINE | cimetidine | TABLET;ORAL | 074316-001 | Feb 28, 1996 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Ani Pharms Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 075110-001 | Jun 18, 1998 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Ani Pharms Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 074610-001 | Sep 26, 1996 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Ivax Sub Teva Pharms | CIMETIDINE | cimetidine | TABLET;ORAL | 074424-003 | Jul 28, 1995 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for cimetidine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-005 | Apr 30, 1986 | Start Trial | Start Trial |
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-003 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-004 | Dec 14, 1983 | Start Trial | Start Trial |
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-003 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.